Literature DB >> 24524933

Consideration of the cellular microenvironment: physiologically relevant co-culture systems in drug discovery.

Ellen L Berg1, Yu-Chih Hsu2, Jonathan A Lee3.   

Abstract

There is renewed interest in phenotypic approaches to drug discovery, using cell-based assays to select new drugs, with the goal of improving pharmaceutical success. Assays that are more predictive of human biology can help researchers achieve this goal. Primary cells are more physiologically relevant to human biology and advances are being made in methods to expand the available cell types and improve the potential clinical translation of these assays through the use of co-cultures or three-dimensional (3D) technologies. Of particular interest are assays that may be suitable for industrial scale drug discovery. Here we review the use of primary human cells and co-cultures in drug discovery and describe the characteristics of co-culture models for inflammation biology (BioMAP systems), neo-vascularization and tumor microenvironments. Finally we briefly describe technical trends that may enable and impact the development of physiologically relevant co-culture assays in the near future.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Assay development; Cell-based assays; Drug discovery; High throughput screening; Inflammation; Lead generation; Primary cells

Mesh:

Year:  2014        PMID: 24524933     DOI: 10.1016/j.addr.2014.01.013

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  16 in total

1.  The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases.

Authors:  Manuel X Duval
Journal:  Exp Biol Med (Maywood)       Date:  2018-08-08

Review 2.  Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment.

Authors:  Guoyou Huang; Fei Li; Xin Zhao; Yufei Ma; Yuhui Li; Min Lin; Guorui Jin; Tian Jian Lu; Guy M Genin; Feng Xu
Journal:  Chem Rev       Date:  2017-10-09       Impact factor: 60.622

Review 3.  High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.

Authors:  Natalia J Martinez; Steven A Titus; Amanda K Wagner; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2015-09-22       Impact factor: 6.098

4.  Tumor cell-targeted delivery of nanoconjugated oligonucleotides in composite spheroids.

Authors:  Kyle Carver; Xin Ming; Rudy L Juliano
Journal:  Nucleic Acid Ther       Date:  2014-12       Impact factor: 5.486

5.  Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.

Authors:  Hilary A Kenny; Madhu Lal-Nag; Erin A White; Min Shen; Chun-Yi Chiang; Anirban K Mitra; Yilin Zhang; Marion Curtis; Elizabeth M Schryver; Sam Bettis; Ajit Jadhav; Matthew B Boxer; Zhuyin Li; Marc Ferrer; Ernst Lengyel
Journal:  Nat Commun       Date:  2015-02-05       Impact factor: 14.919

Review 6.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

7.  3-Dimensional spatially organized PEG-based hydrogels for an aortic valve co-culture model.

Authors:  Daniel S Puperi; Liezl R Balaoing; Ronan W O'Connell; Jennifer L West; K Jane Grande-Allen
Journal:  Biomaterials       Date:  2015-07-21       Impact factor: 12.479

Review 8.  Developments with 3D bioprinting for novel drug discovery.

Authors:  Aishwarya Satpathy; Pallab Datta; Yang Wu; Bugra Ayan; Ertugrul Bayram; Ibrahim T Ozbolat
Journal:  Expert Opin Drug Discov       Date:  2018-11-01       Impact factor: 6.098

Review 9.  Choosing the right cell line for renal cell cancer research.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Michal Fiedorowicz; Camillo Porta; Anna M Czarnecka
Journal:  Mol Cancer       Date:  2016-12-19       Impact factor: 27.401

10.  Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone.

Authors:  Samuel M Meier; Besnik Muqaku; Ronald Ullmann; Andrea Bileck; Dominique Kreutz; Johanna C Mader; Siegfried Knasmüller; Christopher Gerner
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.